Listed by the USPTO as FAUST, AMBER KATHLEEN
Tech Center 1600 • Art Units: 1643 1674
This examiner grants 61% of resolved cases
FAUST, AMBER KATHLEEN is a USPTO patent examiner in Tech Center 1600 and Art Unit 1643. Across 72 resolved cases, the allowance rate is 61.1%, the interview lift is 53.6%, and median time to allowance is 1355 days.
The Regents of the University of California, Sinomab Bioscience Limited, and Janssen Pharmaceuticals Inc. are the leading companies represented. COOLEY LLP, DORITY & MANNING, P.A., and STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. are the leading firms. The interview figure is a prominent feature of the profile, supporting early examiner engagement where technical or claim-scope issues can be clarified before prolonged written prosecution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17612279 | IDENTIFICATION OF RECURRENT MUTATED NEOPEPTIDES | Non-Final OA | Yeda Research and Development Co. Ltd. |
| 18264604 | CHIMERIC ANTIGEN RECEPTOR WITH ENDOGENOUS PROTEIN MOLECULE REPLACING SINGLE DOMAIN ANTIBODY | Final Rejection | ZHEJIANG UNIVERSITY |
| 18249314 | SUSTAINED ANTIBODY AND IMMUNOTHERAPEUTIC DELIVERY TO CERVICAL LYMPH NODES | Non-Final OA | The Johns Hopkins University |
| 18038101 | ENGINEERED T CELLS FOR EXPRESSION OF CHIMERIC ANITGEN RECEPTORS | Final Rejection | The Regents of the University of California |
| 18138679 | TARGETING STROMA-CANCER INTERACTIONS IN CANCER | Final Rejection | The Regents of the University of California |
| 17310279 | TARGETED DELIVERY OF IFN GAMMA USING ANTIBODY FUSION PROTEINS | Final Rejection | The Regents of the University of California |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy61.1% of resolved applications examined by Amber Kathleen Faust were allowed (72 resolved cases), compared with 41.5% across Art Unit 1643 over the last five years.
This examiner's interview lift is +53.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Amber Kathleen Faust took 1,355 days on average from filing to allowance.
Amber Kathleen Faust examines applications in Art Unit 1643 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
